| Mar 31,
2018 | Mar 31,
2019 | Mar 31,
2020 | Mar 31,
2021 | Mar 31,
2022 | Mar 31,
2023 |
|---|
| Net sales | | 1,475,436 | 1,534,800 | 1,618,064 | 1,918,174 | 2,242,824 |
|---|
| Cost of sales | | | | | | |
|---|
| Gross profit | | | | | | |
|---|
| Selling, general and administrative expenses | | | | | | |
|---|
| Research and development expenses | | | | | | |
|---|
| Operating profit (loss) | | | | | | |
|---|
| Finance income | | | | | | |
|---|
| Finance costs | | | | | | |
|---|
| Derivative gain (loss) (IFRS) | | | | | | |
|---|
| Foreign exchange gain (loss) | | | | | | |
|---|
| Share of profit (loss) of investments accounted for using equity method | | | | | | |
|---|
| Profit (loss) before tax | | | | | | |
|---|
| Income tax expense | | | | | | |
|---|
| Profit (loss) from continuing operations | | | | | | |
|---|
| Profit (loss) from discontinued operations | | | | | | |
|---|
| Profit (loss) | | | | | | |
|---|
| Owners of parent | | | | | | |
|---|
| Non-controlling interests | | | | | | |
|---|
| Profit (loss) | | | | | | |
|---|
| Continuing operations | | | | | | |
|---|
| Discontinued operations | | | | | | |
|---|
| Total | | | | | | |
|---|